Arkansas governor Sarah Huckabee Sanders — a former top lieutenant to Donald Trump — is leading a charge against big pharmacy ...

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Lastly, Health Care Benefit adjusted operating income is expected to reach around $1.91 billion, an increase of approximately $400 million. The gain largely reflects the prior-year reserve development ...

DUSA offers a high conviction, value-focused approach with a concentrated portfolio. Learn more about DUSA ETF and my ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

A federal judge on Wednesday said he will try to issue a ruling soon on whether a new state law banning pharmacies operated ...

UnitedHealth Group is under criminal and civil investigation by the DOJ over alleged Medicare fraud, raising serious ...

NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...